Bernheim A
Medizinische Poliklinik und Abteilung für Kardiologie, Universitätsspital Basel.
Praxis (Bern 1994). 2005 Nov 9;94(45):1760-4. doi: 10.1024/0369-8394.94.45.1760.
Hypoxia at high altitude is associated with an increase in myocardial work. Cardiovascular effects of high altitude may affect patients suffering from cardiac diseases and raise questions concerning the tolerability of exposure to altitude. In general, altitudes up to 2500 to 3000 meters do not pose a hazard for a patient with stable coronary artery disease and good exercise tolerance. Likewise, a patient suffering from heart failure does not necessarily refrain from these altitude exposures unless exercise capacity and left ventricular ejection fraction are severely impaired. However, cardiac patients have to be informed that symptoms may occur already at lesser efforts at high altitude compared to low altitude. Therefore, patients should be advised to adapt physical activities, particularly during the first 3-4 days of acclimatization. In commercial airplanes pressure conditions are comparable to altitudes of 1500 to 2400 meters. Most cardiac patients tolerante the associated physical stress without difficulty. Contraindications for air travel include unstable cardiac conditions, recent cardiac interventions (2-3 weeks), an uncomplicated myocardial infarction within the last 2 weeks, or a complicated myocardial infarction within the last 6 weeks, respectively. The risk of exposure to altitudes above 3500 meters is not well known for cardiac patients because of a lack of corresponding data. Thus, patients who would like to mountaineer at very high altitudes have to be advised individually based on their physical condition and on the severity of their cardiac illness.
高海拔地区的缺氧与心肌工作负荷增加有关。高海拔对心血管系统的影响可能会影响心脏病患者,并引发关于暴露于高海拔环境耐受性的问题。一般来说,对于冠状动脉疾病稳定且运动耐量良好的患者,海拔2500至3000米以下不会构成危险。同样,心力衰竭患者不一定必须避免这些海拔暴露,除非运动能力和左心室射血分数严重受损。然而,必须告知心脏病患者,与低海拔相比,在高海拔地区即使付出较少努力也可能出现症状。因此,应建议患者调整体力活动,尤其是在适应的前3 - 4天。在商业飞机上,压力条件相当于海拔1500至2400米。大多数心脏病患者能够毫无困难地耐受相关的身体压力。航空旅行的禁忌症分别包括不稳定的心脏状况、近期心脏干预(2 - 3周)、过去2周内无并发症的心肌梗死或过去6周内复杂的心肌梗死。由于缺乏相应数据,心脏病患者暴露于海拔3500米以上的风险尚不清楚。因此,对于想要在非常高海拔地区登山的患者,必须根据他们的身体状况和心脏病的严重程度进行个体化建议。